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ABSTRACT
Introduction: Patient experience is central to
the quality of healthcare delivery, showing
positive associations with several outcome
measures. The main objectives of this study are
to analyze the influence of patient experience
on the health-related quality of life in people
living with HIV and the role played by treat-
ment complexity and clinical care.
Methods: We conducted a cross-sectional sur-
vey with 467 patients with HIV. We used the
Instrument for Evaluation of the Experience of
Chronic Patients and the Health-related Quality
of Life Questionnaire (EQ-5D-5L). We analyzed
a predictive model through the partial least
squares (PLS) method.
Results: The patient self-management scores
showed the highest positive relationship with
the patient’s health-related quality of life
(b = 0.24, b = 0.32, p\ 0.0001). Patients’ treat-
ment complexity had a negative influence on
health-related quality of life (b = - 0.21,
b = - 0.28, p\ 0.0001). The complexity of
clinical care had negative effects on health-re-
lated quality of life, both directly (b = - 0.37,
b = - 0.19, p\0.0001) and through its nega-
tive influence on the productive interactions
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with healthcare professionals (b = - 0.21,
p\0.0001) and patient self-management fac-
tors (b = - 0.21, p\ 0.0001). The effects of
patient experience dimensions on their health-
related quality of life were higher in people
living with HIV[50 years old (p\ 0.05).
Conclusions: Patient experience mainly influ-
enced the health-related quality of life of older
people living with HIV. The treatment and
clinical care complexity played an important
role in degrading the patients’ experience and
their quality of life. More integrated care would
benefit the health-related quality of life of peo-
ple living with HIV.
Funding: This project was funded by Merck
Sharp & Dohme, Spain.
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INTRODUCTION
An estimated 36.7 million people are living
with HIV worldwide [1], of which approxi-
mately 145,000 live in Spain [2]. Improvements
in antiretroviral therapy (ART) have led to
increased life expectancy for many people living
with HIV. In the last 2 decades, HIV infection
has changed from a subacute infection with a
high mortality rate to a chronic manageable
infection. As a consequence, there has been a
gradual increase in the number of aging people
living with HIV [3]. In 2016, 46.3% of people
living with HIV in Spain were C 50 years of age
[4, 5]. In this scenario, AIDS-defining illnesses
have lost their leading role and have been dis-
placed by the different comorbidities related to
age and the geriatric syndromes themselves [4].
However, several HIV-related problems still
have a notable impact on health-related quality
of life, even in virally suppressed people living
with HIV as a result of taking ART [6], and this
could have a negative impact in their health
outcomes [7].
To address the wellbeing of people living
with HIV constitutes a big challenge for
healthcare systems [8]. It implies improving the
model of care to face the complexity of
addressing not only the combined burden of
HIV and its comorbidities [4, 9] but also other
issues related to the health-related quality of life
of people living with HIV [8]. This requires a
patient-centered approach that involves patient
engagement as well as the widespread use of
innovations in chronic care [10]. In this con-
text, having information about the patient’s
experience can provide relevant information to
improve the quality of care [10–12]. Patient
experience is defined as the information that
patients provide to facilitate their continued
interaction with health and social care profes-
sionals and services and their experience of that
interaction and its outcomes [10]. Patient
experience has been recognized as a central
issue in the quality of healthcare delivery to
patients along with clinical effectiveness and
patient safety across a wide range of disease
areas [12].
The present study is a secondary analysis of
broader research that has evaluated the experi-
ence of chronically ill patients (diabetes melli-
tus, HIV, inflammatory bowel disease, and
rheumatic diseases) with healthcare. For this
purpose, it used the Instrument for Evaluation
of the Experience of Chronic Patients (IEXPAC)
Questionnaire [10]. This scale is one of the most
recent instruments developed, which incorpo-
rates a broad notion of integrated care. Results
of the principal analysis showed that people
living with HIV presented better overall expe-
rience with healthcare than patients with other
chronic conditions. It also revealed that treat-
ment and clinical care complexity had a nega-
tive association with better patient experience.
The primary analysis was described elsewhere
[13].
The present analysis aimed to go one step
further, analyzing the influence of the different
dimensions of patient experience on the health-
related quality of life of people living with HIV.
To our knowledge, hardly any studies have
assessed such influence. We also analyzed the
role played by the treatment and clinical care
complexity of people living with HIV in the
relationship between patient experience and
health-related quality of life.
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METHODS
Study Population and Procedures
We conducted a cross-sectional survey in which
467 people living with HIV participated. They
were recruited by convenience sampling. The
general inclusion criteria were: HIV? diagno-
sis, C 18 years, and having multiple morbidi-
ties. The present study is part of broader
research that evaluated chronically ill patients’
experience with healthcare [13].
HIV care in Spain is provided in tertiary care
settings (i.e., public hospitals) through specific
HIV clinics within the infectious diseases units.
Antiretroviral drugs are dispensed in hospital
pharmacies by specialized personnel. Access to
the Spanish healthcare system is universal, and
almost all patients are treated in hospitals that
belong to the public healthcare system. People
livingwithHIVmaybe attended in a primary care
setting for conditions attended in primary care
(i.e., non-HIV-related comorbidities). HIV spe-
cialists from 25 HIV clinics across Spain collabo-
rated in the recruitment of participants. During
their consultations, they explained the goal of the
study to the patients and proposed their partici-
pation. They requested them to complete the
surveyvoluntarily andanonymously athomeand
then return it by pre-paid mail.
To minimize selection bias, each physician
offered participation in the study to the first 25
consecutive patients attending the clinic rou-
tinely, regardless of age, sex, disease severity, or
any other criteria. Survey distribution and col-
lection were conducted between May and
September 2017. The survey was handed to 627
patients and was returned by 467 patients (re-
sponse rate of 74.72%).
The Clinical Investigation Ethics Committee
of the Gregorio Marañón Hospital of Madrid
(Spain) approved the research protocol. The study
documentation included printed instructions and
information for patients about the anonymous
nature of the survey and aggregated data pro-
cessing, which ensured that patient identification
was not possible. As agreed by the Clinical
Investigation Ethics Committee, the voluntary
return of completed questionnaires was taken as
implied consent to participate in the study. No
clinical data were collected in this study.
Instrument
The survey contained the following variables:
Instrument for Evaluation of the Experience of
Chronic Patients (IEXPAC) [10]. It includes 11
items, plus an additional item for recently hos-
pitalized patients. The items refer to the last
6 months, except for the question about hospi-
talization, which refers to the previous 3 years,
and they have a five-option Likert scale response
(always, mostly, sometimes, seldom, and never).
The first 11 items have a three-factor structure.
Factor 1 is called productive interactions and
refers to the characteristics and content of inter-
actions between patients and professionals
designed to improve outcomes. Factor 2, the new
relational model, refers to new forms of patient
interactions with the healthcare system, through
the internet, or with peers. Finally, factor 3, called
patient self-management, refers to individuals’
ability to cope with their diseases, manage their
self-care, and improve their wellbeing, based on
interventions mediated by healthcare profession-
als. The results of the Spanish validation study of
this instrument showed good fit indices (SMRS =
0.05, GFI = 0.96, and CFI = 0.96) and reliability
of the factors (PI = 0.91, NRM = 0.90, and PSM =
0.95) [10].
Health-related Quality of Life Questionnaire
(EQ-5D-5L) [14, 15]: The EQ-5D-5L is a stan-
dardized generic measure that comprises five
dimensions (mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression) with
five levels each (no problems, slight problems,
moderate problems, severe problems, and
extreme problems). The instrument also con-
tains a visual analog scale (EQ-VAS) that records
the respondent’s self-rated health on a 20-cm
vertical scale with end points labeled ‘‘the best
you can imagine’’ and ‘‘the worst you can
imagine.’’ We used the validated Spanish ver-
sion of this measure.
The survey also contains the following vari-
ables: (1) complexity of clinical care—number
of different physicians seeing the patient and
number of different healthcare sites that the
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patient usually attends; (2) complexity of the
patient’s treatment—number of different
medicines that the patient takes and the num-
ber of daily doses of the treatment the patient
takes. Finally, the survey collected primary
general demographic data (sex, age, educational
level, and current occupational status).
The survey can be consulted in the Electronic
Supplementary Material of Orozco-Beltrán et al.
[13]. All the survey was designed and adminis-
tered in Spanish.
Data Analysis
First, we performed an exploratory analysis. Next,
we analyzed differences in the target variables
according to participants’ gender and age.
Regarding age, we established the cutoff point,
generally accepted in HIV, of 50 years to consider
the health impact of aging in people living with
HIV [4] (group 1 B 49 years, group 2 C 50 years).
Following that, we adopted a predictive
model based on correlations between the stud-
ied variables and previous results of our research
[13] through the partial least squares (PLS)
method, using the SmartPLS 3.0 software. The
partial least squares is a variance-based tech-
nique recommended at an early stage of the
theoretical development to test and validate
exploratory models [16, 17]. In the partial least
squares analysis, the relationships among the
studied constructs were analyzed using linear
regression in which the loads could be inter-
preted as standardized beta coefficients. The
confidence intervals were based on bootstrap-
ping 500 samples that allowed the generaliza-
tion of the results and the computation of
Student’s t for each hypothesis [18]. The coeffi-
cient of explained variance (R2) of each
endogenous latent variable should be [ 0.10
[19]. No assumption of normality of the distri-
butions is required [20].
To assess the specific contribution of the
variables studied, we first determined whether
both measures of health-related quality of life
(EQ-5D-5L and EQ-VAS) could be predicted by
the factors of the Instrument for Evaluation of
the Experience of Chronic Patients. Second, we
introduced treatment complexity in the model.
Next, we introduced the complexity of clinical
care. We assessed the effect sizes of the models
tested through the f2 statistic. Values of 0.02,
0.15, and 0.35 indicate small, medium, and
large effects, respectively [17].
Finally, we evaluated the effect of aging in the
model, comparing the final model in the two age-
specific groups established (G1 B 49 years,
G2 C 50 years). For this purpose, we first con-
ducted the measurement invariance of composite
models (MICOM) procedure in PLS. If the results
support the measurement invariance, a multi-
group analysis could be conducted to compare
the path coefficients of the structural model.
However, if the measurement invariance is not
established, a multigroup analysis is not feasible,
and thus it is recommended to analyze the groups
separately [21].
RESULTS
Most participants were male (73.5%). Mean age
of the participants was 51.6 (SD = 10.9). A total
of 44.3% were working, 34.3% were retired or
occupationally disabled, 16.7% were unem-
ployed, and 4.8% had another occupation
(student or housework). The majority of the
participants had studied primary (42.4%) or
secondary education (35.9%), and 21.7% had a
university degree.
Correlations Among the Variables Under
Study and Differences According
to Participants’ Characteristics
The descriptive statistics of the variables used in
the model, as well as the correlations among the
variables, are shown in Table 1.
Results showed that female patients’ self-
management score was higher than that of
males (4.24 ± 0.66 vs. 4.08 ± 0.82, t = - 1.97,
p = 0.50, Cohen’s d = 0.20). Regarding age,
those older than 50 (n = 227) presented signifi-
cantly higher scores in the productive interac-
tions factor of the Instrument for Evaluation of
the Experience of Chronic Patients than those
younger than 49 years (n = 146), (4.54 ± 0.067,
t = 2.09 vs. 4.37 ± 0.075; t = 2.09, p = 0.37;
Cohen’s d = - 0.23). They also showed
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significantly higher scores in their treatment
complexity (1.54 ± 0.55 vs. 1.24 ± 0.38;
t = - 5.85; p\0.0001; Cohen’s d = 0.61) and
clinical care complexity (6.60 ± 5.09 vs.
5.17 ± 4.18; t = - 2.82; p = 0.005; Cohen’s
d = 0.30) than the younger group. Lastly, they
also showed the lowest score in the overall
perception of health (69.74 ± 19.05 vs. 79.05
vs. 17.54; t = 4.57; p\0.0001; Cohen’s
d = - 0.50).
Model Testing
Step 1: The influence of the experience of
people living with HIV with
healthcare on their health-related
quality of life.
The first step was to test whether health-related
quality of life could be predicted by the differ-
ent dimensions of the patient experience
(Fig. 1). Results showed that patient self-man-
agement was the only factor that was positively
and significantly associated with both health-
related quality of life measures (EQ-5D-5L:
b = 0.34, p\ 0.0001; and self-rated health, EQ-
VAS: b = 0.38, p\ 0.0001). The relationship
between the productive interactions and the
new relational model with the two health-re-
lated quality of life measures was nonsignifi-
cant, although in the former (productive
interactions with health-related quality of life),
the path coefficients showed a negative, albeit
minimal, direction (productive interactions EQ-
Table 1 Correlations among the variables and descriptive statistics
Variables PI NRM PSM CT CCC EQ-5D EQ-
VAS
M – SD
1. Productive interactions (PI)a 1 4.44 ± 0.71
2. New relational model
(NRM)a
0.29** 1 2.00 ± 1.04
3. Patient self-management
(PSM)a
0.73** 0.40** 1 4.12 ± 0.79
4. Complexity of treatment
(CT)b
- 0.16** - 0.04 - 0.11* 1 1.42 ± 0.53
5. Complexity of clinical care
(CCC)c
- 0.21** - 0.05 - 0.18** 0.41** 1 5.83 ± 4.81
6. Health-related quality of life
(EQ-5D)a
0.16** 0.08 0.14** - 0.39** - 0.42** 1 4.51 ± 0.59
7. Self-rate of health (EQ-
VAS)d
0.26** 0.14** 0.28** - 0.42** - 0.36** - 0.57** 73.25 ± 19.13
Correlations were analyzed using Pearson’s coefficients (r)
M mean, SD standard deviation, PI productive interactions, NRM new relational model, PSM patient self-management,
EQ-5D five dimensions of the Health-Related Quality of Life Questionnaire, EQ-VAS analog visual scale measuring self-rate
of health, CT complexity of the treatment, CCC complexity of the clinical care
*p\ 0.01; **p\ 0.001
a The scales have a range of 5 points
b The variable complexity of treatment has a range of 4 points (it averages the number of diary doses ranged from 1 to 4 and
the number of different medicines, which was rescaled to 4 points)
c The variable complexity of patient’s clinical care averages the number of different physicians seeing the patient and
number of different health-care sites that the patient usually attends
d The scale has a range of scores between 0 and 100 points
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5D-5L: b = - 0.07, p = 0.26; productive inter-
actions self-rate of health, EQ-VAS: b = - 0.00,
p = 0.97; new relational model EQ-5D-5L:
b = 0.02, p = 0.63, and new relational model
EQ-VAS: b = 0.05, p = 0.21). The model
explained more variance in the self-rated
health—EQ-VAS (R2 = 0.16) than that of the
EQ-5D-5L (R2 = 0.09).
Summarizing the first step of the model
testing, we can conclude that only the dimen-
sion of patient-self management positively and
significantly predicted people living with HIVs’
health-related quality of life.
Step 2: The influence of treatment complexity
on health-related quality of life.
In the second step, we introduced treatment
complexity into the model (Fig. 2). Results
showed that it was negatively associated with
both measures of health-related quality of life
(EQ-5D-5L: b = - 0.37, p\ 0.0001, and self-
rated health (EQ-VAS): b = - 0.36, p\ 0.0001).
The introduction of treatment complexity in
the model increased the amount of explained
variance of health-related quality of life, show-
ing a medium effect size in both the explana-
tion of the 5D-5D-5L scale (R2 = 0.22; f2 = 0.17)
and self-rated health scale (EQ-VAS) (R2 = 0.29;
f2 = 0.18). Thus, this model had a higher pre-
dictive capacity of the people with HIV health-
related quality of life than the previous one
(model tested in Step 1).
Step 3: The influence of the complexity of
clinical care on the model.
Finally, we introduced the complexity of
clinical care into the model (Fig. 3). Results
showed that it was negatively associated with
the productive interactions and patient self-
management factors of the patient experience
Fig. 1 Results of the partial least squares inner model
showing the predictive relationships between the dimen-
sions of patient experience and health-related quality of life
(step 1 of the model testing). Standardized solution. For
the sake of clarity, only the significant path coefficients are
displayed in the figure. Student t statistics and p values of
the path coefficients (b) are displayed in Table 3. PI
productive interactions, NRM new relational model, PSM
patient self-management, EQ-5D five dimensions of the
Health-related Quality of Life Questionnaire, EQ-VAS
analog visual scale measuring self-rate of health
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(b = - 0.21, p\0.0001, and b = - 0.21,
p\0.0001, respectively). Complexity of clinical
care was also negatively associated with both
health-related quality of life measures (EQ-5D-
5L: b = - 0.37, p\ 0.0001, and self-rated health
(EQ-VAS): b = - 0.19, p\ 0.0001). Moreover,
the negative relationship between the com-
plexity of clinical care and the productive
interactions factor led to an increased negative
relationship of this factor on the EQ-5D-5L
measure of health-related quality of life. The
introduction of the complexity of clinical care
in the model increased the amount of explained
variance of the EQ-5D-5L health-related quality
of life measure, showing a medium effect size
(R2 = 0.32, f2 = 0.17). However, the effect size
was weak in the case of self-rated health (EQ-
VAS) (R2 = 0.31, f2 = 0.03). Thus, this model
had a higher predictive capacity of the people
with HIV’s health-related quality of life than the
two previous ones (models tested in step 1 and
step 2).
Summarizing the results of the final model,
we could observe that patient self-manage-
ment showed the highest positive relationship
with the patient’s health-related quality of
life. On the contrary, the productive interac-
tions presented a negative relation with the
EQ-5D-5L measure of health-related quality of
life. Furthermore, the complexity of patients’
treatment also predicted their health-related
quality of life negatively. Finally, the com-
plexity of clinical care also damaged health-
related quality of life, both directly and
through its negative influence on the pro-
ductive interactions with healthcare profes-
sionals and patient self-management
dimensions of the patient experience. The
introduction in the model of the complexity
of treatment and clinical care increased the
predictive capacity of the model. Table 2 dis-
plays the total effects of the variables on the
health-related quality of life.
For the sake of clarity, only the relationships
among the latent variables (inner model) are
Fig. 2 Results of the partial least squares inner model
showing the predictive relationship of the treatment
complexity and health-related quality of life (step 2 of
the model testing). Standardized solution. For the sake of
clarity, only the significant path coefficients are displayed
in the figure. Student t statistics and p values of the path
coefficients (b) are displayed in Table 3. PI productive
interactions, NRM new relational model, PSM patient self-
management, EQ-5D five dimensions of the Health-related
Quality of Life Questionnaire, EQ-VAS analog visual scale
measuring self-rate of health, CT complexity of the
treatment
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Fig. 3 Results of the final partial least squares inner model
showing the predictive relationships among the studied
variables after introducing the complexity of the clinical care
into the model (step 3 of the model testing). Standardized
solution. For the sake of clarity, only the significant path
coefficients are displayed in the figure. Student t statistics and
p values of b coefficients are displayed in Table 3. PI
productive interactions, NRM new relational model, PSM
patient self-management, EQ-5D five dimensions of the
Health-related Quality of Life Questionnaire, EQ-VAS analog
visual scale measuring self-rate of health, CT complexity of
the treatment, CCC complexity of the clinical care
Table 2 Total effects of the variables on participant’s health-related quality of life considering the total sample and age-
specific groups
Latent variables Total effectsa
Total sample £ 49 years ‡ 50 years
EQ-5D VAS EQ-5D VAS EQ-5D VAS
Productive interactions - 0.12 - 0.04 - 0.17 - 0.06 - 0.16 - 0.17
New relational model 0.03 0.05 0.03 0.06 0.11 0.11
Patient self-management 0.24 0.32 0.17 0.18 0.28 0.46
Complexity of treatment - 0.28 - 0.21 - 0.32 - 0.28 - 0.16 - 0.23
Complexity of clinical care - 0.40 - 0.25 - 0.43 - 0.35 - 0.38 - 0.26
R2 (explained variance) 0.32 0.31 0.31 0.41 0.28 0.34
EQ-5D five dimensions of the Health-related Quality of Life Questionnaire, EQ-VAS analog visual scale of Health-related
Quality of Life Questionnaire measuring self-rate of health
a Total effects are the statistics displayed in the table showing the total effects (multiplication of direct and indirect effects)
of the predictors on health-related quality of life
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displayed in the figures. Table 3 shows all the
statistics and parameters of the partial least
square algorithm and bootstrapping of the
structural model. The results of the relation-
ships among the latent variables, and its item
indicators (measurement model) are provided as
Electronic Supplementary Material 1. Results
showed that the loadings of most indicators of
the latent variables (k) were[ 0.50, which can
be considered adequate [17]. Most variables also
presented adequate construct reliability and
validity. The factor ‘‘new relational model’’ had
the lowest reliability, although it could be
considered adequate, as it had only three indi-
cators [22]. The patient self-management factor
showed the lowest value of convergent validity,
but it was close to 0.50 [average variance
extracted (AVE) = 0.44], a value that can be
considered adequate [17].
Differences According to Age
in the Predictive Model
To test whether the model was invariant or
equivalent across the established age-specific
groups (G1 B 49 years, G2 C 50 years), we first
assessed the measured model invariance. Con-
figurational invariance was assumed because
constructs were equally parameterized and
estimated across groups. Regarding composi-
tional invariance, results of the measurement
invariance of the composite model procedure
showed that the correlations between the
composite scores of the two groups were not
significantly \ 1 in most variables except for
treatment complexity (permutation p = 0.022).
Thus, partial measurement invariance or
equivalence cannot be established for this latent
variable. Results of the assessment of
Table 3 Results of the partial least square algorithm and bootstrapping of the final model in the total sample and in the age-
specific studied groups
Path coefficients Total sample £ 49 years ‡ 50 years
b t p b t p b t p
Productive interactions EQ-5D - 0.12 2.06 0.039 - 0.17 1.45 0.146 - 0.16 1.96 0.050
Productive interactions EQ-VAS - 0.04 0.81 0.416 - 0.06 0.54 0.588 - 0.17 2.11 0.035
New relational model EQ-5D 0.03 0.88 0.377 0.04 0.45 0.653 0.11 2.08 0.037
New relational model EQ-VAS 0.05 1.25 0.210 0.06 0.64 0.519 0.11 1.93 0.054
Patient self-management EQ-5D 0.24 4.16 \ 0.0001 0.17 1.29 0.195 0.28 3.41 0.001
Patient self-management EQ-VAS 0.32 5.57 \ 0.0001 0.18 1.42 0.156 0.46 5.49 \ 0.0001
Complexity of treatment EQ-5D - 0.21 4.12 \ 0.0001 - 0.32 3.74 \ 0.0001 - 0.15 2.47 0.014
Complexity of treatment EQ-VAS - 0.28 6.50 \ 0.0001 - 0.28 4.05 \ 0.0001 - 0.23 3.21 0.001
Complexity of clinical care EQ-5D - 0.37 7.26 \ 0.0001 - 0.41 5.02 \ 0.0001 - 0.35 4.91 \ 0.0001
Complexity of clinical care EQ-VAS - 0.19 4.41 \ 0.0001 - 0.31 3.70 \ 0.0001 - 0.20 3.02 0.003
Complexity of clinical care productive
interactions
- 0.21 4.58 \ 0.0001 - 0.20 2.27 0.024 - 0.18 3.03 0.002
Complexity of clinical care patient self-
management
- 0.21 4.87 \ 0.0001 - 0.31 3.61 \ 0.0001 - 0.19 2.82 0.005
b standardized beta coefficients, t Student’s t, EQ-5D five dimensions of Health-related Quality of Life Questionnaire, EQ-
VAS analog visual scale of Health-related Quality of Life Questionnaire measuring self-rate of health
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compositional invariance procedure are pro-
vided in Electronic Supplementary Material 2.
Consequently, we analyzed the predictive
model separately in the two age-specific sub-
samples. Results showed that the path coeffi-
cients among the three factors of the patient
experience and both measures of the health-
related quality of life (EQ-5D-5L and EQ-VAS)
were only significant in those people living with
HIV C 50 years (Table 3). Thus, the total effects
of these factors of patient experience on health-
related quality of life were higher in the people
living with HIV C 50 years than in
those B 49 years (Table 2), and they were sig-
nificant only in the older group (p\0.05). The
highest effect size in this group was the positive
relationship between the factor patient self-
management and self-rated health (f2 = 0.16).
However, the complexity of treatment and
clinical care produced the highest total effects
in the people living with HIV B 49 years, and
the path coefficients between these variables
and the health-related quality of life EQ-5D-5L
measure had the highest effect sizes in this
group (f2 = 0.15 and f2 = 0.23 for the complex-
ity of treatment and the complexity of clinical
care, respectively).
DISCUSSION
The present study aimed to analyze the influ-
ence of different factors of patients’ experience
on the health-related quality of life of people
living with HIV and the role that the complex-
ity of the treatment and clinical care played in
it. Furthermore, it analyzed differences in those
relationships according to whether the partici-
pants were younger or older than 50 years,
which is a suggested cutoff point to consider the
health impact of aging in people living with
HIV [4].
Results of the model tested in the total
sample showed that patient self-management
was the only dimension of patients’ experience
that positively predicted the health-related
quality of life of people living with HIV. Several
studies have shown the central role that patient
self-management plays in the health and well-
being of patients living with chronic diseases
[23, 24]. Programs of training patients in self-
management behaviors led to an improvement
of health status, reduction of hospital admis-
sions, and the costs of healthcare [23]. Such
training also improves healthy behaviors and
health outcomes of people living with HIV
[25, 26].
However, patients’ experience itself
explained a limited amount of the variance of
the health-related quality of life. It is because
treatment and clinical care complexity played a
relevant role in their relationship. The treat-
ment complexity of people living with HIV had
a direct negative association with their health-
related quality of life. Previous studies have
found a negative influence of complex treat-
ments in people living with HIV wellbeing
[27, 28] and the risks of polypharmacy in aging
people living with HIV who are suffering
comorbidities [4]. The complexity of patients
with HIV’s clinical care also had a direct nega-
tive influence on their health-related quality of
life. However, it also damaged their health-re-
lated quality of life indirectly through its nega-
tive effects on the productive interactions of
people living with HIV with healthcare profes-
sionals and their health self-management. The
complexity of clinical care might make inter-
actions with healthcare providers negative or
unproductive and hinder the self-management
of their health. Previous results from our
broader research showed that some variables
related to the complexity of clinical care were
negatively associated with all factors of the dif-
ferent chronic patients’ experience [13]. Our
secondary analysis showed their impact not
only on HIV patients’ experience but also on
their health-related quality of life.
Our results also showed that the effects of
the dimensions of patient experience on their
health-related quality of life were higher in
people living with HIV older than 50 years than
those who were younger. The highest positive
influence of patient self-management on
health-related quality of life occurred in this
group. Moreover, the new relational model
influenced the health-related quality of life in
those older than 50 years but not of the younger
patients. The management of the HIV aging
process implies an increased challenge for both
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patients and healthcare providers [29, 30].
According to our results, it seems that patients’
experience with healthcare professionals is
particularly relevant in the management of the
aging process of people living with HIV. There is
currently a scientific debate on the need for a
new healthcare model that responds effectively
to the emerging challenges related to the aging
process of people living with HIV [4, 31]. Les-
sons learned from the management of other
chronic diseases point out the need to move
toward patient-centered models such as the
Chronic Care Model [24].
Results also showed that, although people
living with HIV older than 50 years presented
higher scores in the complexity of treatment
and clinical care than those younger than 50,
such complexity produced a higher negative
effect on the health-related quality of life of the
latter group (B 49 years). A possible explanation
for this increased burden in younger patients’
health-related quality of life may be that they
have less mastery and skills to deal with such
complexity and they are less resilient than the
older patients, who had probably lived more
time with HIV and other comorbidities. Mas-
tery, acceptance of illness, self-care, and illness
perception were some of the factors found to be
related to resilience in the physically ill, and
some studies found that old age was related to
being more adaptive and resilient [32].
Our study has some limitations: first, those
derived from its cross-sectional nature, which
precludes establishing causal relationships
among the variables under study. Future studies
should confirm our results using a longitudinal
approach. Also, we did not perform probabilis-
tic sampling, but the consecutive inclusion of
patients aimed to reduce selection bias. More-
over, because the survey was anonymous, we
could not know the profiles of the people living
with HIV who did not return the survey. A lar-
ger sample is necessary to strengthen the com-
parisons according to age and generalize the
results. Besides, time since HIV diagnosis was
not collected because it was neither the primary
nor secondary objective of the study, and the
research team decided to collect the minimum
data to facilitate quick answers of the partici-
pants and thus get a large sample. However,
time since HIV diagnosis could have an impact
on the patient’s experience and their quality of
life. Some of the results found in our study
related to age could reflect not only the effect of
age, but also their interaction with time since
HIV diagnosis. Future studies should deeply
analyze the effects of time living with HIV in
the patient experience and their quality of life.
CONCLUSION
In summary, the present study found that
patients’ experience with healthcare was asso-
ciated mainly with the health-related quality of
life of aging of people living with VIH. Patient
self-management showed the highest positive
relation with their health-related quality of life.
Treatment and clinical care complexity played
an important role in damaging patients’ expe-
rience and their health-related quality of life.
The World Health Organization recognizes
patient self-management as the best practice to
improve clinical care and outcomes in chronic
patients [33]. Our results highlight the need for
more integrated care for people living with HIV
because it has been shown to have beneficial
effects on several chronic health-related out-
comes and on the quality of patient care [34].
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